医学
肝细胞癌
放射治疗
联合疗法
肿瘤科
不利影响
阶段(地层学)
倾向得分匹配
临床终点
内科学
临床试验
古生物学
生物
作者
Ning Cong,Xinmu Zhang,Yanyu Wang,Xu Yang,Xiaobo Yang,Jiashuo Chao,Ziyu Xun,Jingnan Xue,Yunchao Wang,Huishan Sun,Yiran Li,Nan Zhang,Chengpei Zhu,Xiaorong Hou,Xinting Sang,Haitao Zhao
标识
DOI:10.1016/j.ijrobp.2023.07.001
摘要
In comparison to the combination of ICIs and antiangiogenic therapy, the inclusion of RT has been observed to improve the DCR and survival outcomes in patients with advanced-stage HCC. The safety profile of this triple therapy was satisfactory.
科研通智能强力驱动
Strongly Powered by AbleSci AI